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The effect of isotretinoin currently used in dermatological treatments was investigated on the 
morphology and palate development during organogenesis in rat fetuses. This was in an attempt to 
evaluate the morphological implications associated with isotretinoin consumption. The animals were 
randomly divided into groups: A, B and C. Group A was further divided into subgroups: A1 and A2 and 
administered orally with 35  and 70 mg of isotretinoin (dissolved in vegetable oil) per kg of average 
body weight on day 11 of gestation. The same subdivision and administration goes for groups B and C, 
but on days 12 and 13, respectively. The control group received an equivalent volume of vegetable oil 
for each group on gestational days: 11, 12 and 13. After delivery, the fetuses were weighed and studied 
morphometrically and microscopically. The results revealed that group A had most of the primary 
palate affected (78.61and 88.89% for subgroups 1 and 2, respectively); group B had most of the 
secondary palate affected (50.00 and 71.43% for subgroups 1 and 2, respectively) while majority of the 
fetuses in group C only showed mild malformation both in the primary and secondary palate (28.57 and 
35.72% for sub groups 1 and 2, respectively). The data from morphometric parameters showed that the 
effect of isotretinoin on the fetuses is dose dependent. Isotretinoin should therefore be taking with 
caution especially by pregnant women during the first and second trimester of pregnancy.   
 





Teratology is the study of abnormal development. It is an 
aspect of science that studies the how and why of 
abnormal development. The mystery behind teratology is 
that certain stages of embryonic development are more 
vulnerable to disruption than others. Gregg (1941) 
provided an audience that an environmental influence 
(rubella virus) could cause cataracts and other develop-
mental disruptions if it was present during the critical 
period of human development of the eyes, ears and 
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LaRossa, 2000) that focused attention on the role of 
drugs in the ethnology of human birth defect.  Isotretinoin 
is a medication used for the treatment of severe acne. It 
is sometimes used in prevention of certain skin cancers. 
It is a retinoid, meaning it derives from vitamin A and is 
found in small quantities naturally in the body. Oral 
isotretinoin is marketed under various trade names, most 
commonly Accutane. 
Isotretinoin is still being employed tropically and sys-
temically in dermatological treatments even after it has 
become evident that it caused vital side effect (Amichai et 
al., 2006). Retinoic acid, a derivative of vitamin A just as 
isotretinoin, has been reported to result in delayed palatal 
shelf elevation and subsequent clefts in the secondary 
palate (Hendrickx et al., 1980). Going by the dynamic and  











complexity in palate development, Hendrickx et al. (1980) 
were not surprised that the system is susceptible to 
change in retinoic levels. This is because it was evid-
enced that experimental manipulation of retinoic status 
during development alters normal transforming growth 
factor beta (TGF-beta) status.  Eleny et al. (2001) com- 
pared the tooth germs of the first maxillary and 
mandibular molars of fetal mice subjected to isotretinoin. 
The results showed that the epithelial cells and the first 
molar germs of the isotretinoin-treated animals showed 
delay development. Retinoic acid is teratogenic in 
humans at very low doses. The critical exposure time is 
between 3 - 5 weeks of pregnancy, often before the 
woman knows she is pregnant. Isotretinoin is the active 
ingredient in Accutane®, a drug used to treat severe 
acne (Chee Hong and Isaac, 2003). Since its introduction 
in September 1982, an estimated 160,000 women of 
child bearing age have ingested the drug. Between 1982 
and 1987, approximately 900 - 1,300 malformed children, 
700 - 1000 spontaneous abortion and 5000 - 7000 
elective abortions are due to Accutane® (O’Donnell, 
2003). The structural analogues of vitamin A which 
include isotretinoin and tretinoin are different just in the 
acid tail direction (Giovanna, 1992). The chemical 
structure of isotretinoin is presented in Figure 1.  
The effect of isotretinoin on the secondary palate has 
been studied by the following authors: Lorente et al. 
(1978), Kronmiller et al. (1992), Webster et al., (1986) 
and Ofusori (2003). The literature is almost completely 
lacking in information about definitive effect of isotretinoin 
on the morphology of the fetuses including cleft lip and 
cleft (primary) palate. On the other hand, all the reports 
were centered on the secondary palate. Lammer et al 
(1985) also reported that the exposure of retinoic acid 
during pregnancy may result in craniofacial alterations 
which include cleft in the secondary palate. 
Since drugs that are systemic dependent can present 
an anormaly in developing structures, we set to inves-
tigate the teratogenic effect of isotretinoin on the closure 
between maxillary prominences and the medial nasal 
prominences, palatal shelves elevation and morpholo-
gical alterations in rat fetuses during organogenesis. This 
is in line with the conclusion of Eun-Hwang et al., (1996) 
who revealed that craniofacial anormaly (cleft palate in 
particular) could be observed postnatally while elevated 
maternal serum alpha-fetoprotein is a useful tool for pre-
natal  cleft  palate detection. 
 
 
MATERIALS AND METHODS 
 
Care of the animals and experimental design 
 
Thirty six adult female albino rats (Wistar strain) weights between 
150 – 200 g were used for the experiment. They were maintained 
with granular ration (Bendel feeds, Ilorin, Nigeria) and provided with 
water ad libitum. The environmental condition is as follows: 
temperature of 20oC and relative humidity of approximately 50%. 
The animals were randomly assigned into groups A, B and C (n = 
12). The animals were acclimatized for two weeks in the animal 
holdings of Department of Human Anatomy University of Ilorin, 
Nigeria. Group A was further subdivided into A1 and A2 (n = 4) 
and administered orally (using metallic oropharyngeal canula 
and calibrated hypodermic syringe) with 35 and 70 mg of 
isotretinoin (dissolved in vegetable oil) per kg of average body 
weight on day 11 of gestation. The same subdivision and 
administration goes for groups B and C, but on days 12 and 13 
respectively. The control group for each group (n = 4) received an 
equivalent volume of vegetable oil on gestational days 11, 12 and 
13. The care and handling of the animals conform to the rules and 




Procedure for mating animals 
 
Vagina smear test was first taken on a daily basis prior to mating. 
This was done to observe the ovulating circle of the female rats. 
These smears were examined under light microscope to identify the 
cells and monitor the stage of the estrus circle. This was being 
carried out between the hours of 7 – 9 am every day (Mandi, 1951). 
The predominant presence of uniformly large nucleated  epithelial 
cells indicated pro estrus stage, large squamous cells which are 
leave-like in shape (cornified cells) indicated estrus stages 
(ovulation has occurred) and predominant presence of leucocytes 
with or without epithelial cells indicated the diestrus stage I and II 
which is the longest. The normal estrus cycle takes a total period of 
about 4 - 5 days. At the proestrus stage is when the male Wistar 
rats were introduced in order to mate the female. Normal vagina 
smear were still carried out after the introduction of  the  male.  This  




Table 1. Maternal average weight record before pregnancy and after delivery (g). 
 
Group Parameter Control Subgroup 1 Subgroup 2 
Initial weight 161.3 153.5 153.3  
A Final weight 163.1 149.2 148.0 
Initial weight 178.6 163.3 161.0  
B Final weight 180.2 158.3 154.5 
Initial weight 157.3 166.6 150.0  



















22.32 ± 0.01 
1.11 ± 0.07 
6 
20.01 ± 0.02* 
0.94 ± 0.05* 
14 
19.47 ± 0.23* ** 





22.31 ± 0.08 
1.13 ± 0.07 
5 
20.76 ± 0.19* 
1.05 ± 0.08* 
14 
20.16 ± 0.22* ** 





22.32 ± 0.06 
1.14 ± 0.05 
3 
21.10 ± 0.17* 
1.12 ± 0.19 
14 
21.00 ± 0.18* ** 
1.02 ± 0.08* 
14 
 
C-R = Crown-rump; WT = weight; NO = numbers of litters. *P<0.05 (significant) vs. control; **P<0.05 (significant) subgroup 1 




was being aimed at detecting the presence of spermatozoa in the 
smear and the day when spermatozoa were observed or vagina 
plug noticed was taken as the first day of pregnancy and based on 
this, the age of the pregnancy was determined. 
 
 
Collection of fetuses 
 
The animals were weighed before pregnancy and after delivery. At 
the end of the gestational days, the number of viable fetuses was 
recorded. The crown-rump length of the fetuses were taken using a 
flexible tape measure and recorded to the nearest millimeter. The 
weight of the fetuses and the placenta were taken using a sensitive 
(P153) Metler balance and recorded to the nearest grams. The 
head of the fetuses were decapitated and the regional craniofacial 
anormally studied using Celestron dissecting microscope (Ritchie 
and Webster, 1991). All the fetuses were critically observed for any 





Values of some data were expressed as mean ± SEM and analyzed 
by students’ t-test using statistical software STATISTICA VERSION 







During the period of administration to  the  end  of  gesta- 
tion, a drop in the fur of the treated groups was noticed. 
This observation was concomitant with a loss in weight in 
the animals. The loss in weight in the treated animals 
was observed to be dose dependent (Table 1). 
 
 
Fetal observation  
 
A close observation of the experimental fetuses showed 
that most of the fetuses present some adverse condition 
of ill health. Even though all the fetuses were viable 
(Table 4), there is weight loss in the treated group as 
compared with the control (Table 2). The weight loss is 
dose dependent as the weights of the animals in 
subgroup 2 (administered with 70 mg/kg of isotretinoin) 
were significantly different from those in subgroup 1 
(Table 2). The mean weights of the placenta were 
observed to be low in subgroup 1 and control (Table 3). 
Fetuses got from group A were observed and the primary 
palate was mostly affected. Animals with bilateral cleft lip 
with cleft palate (BCLP) were higher in percentage than 
unilateral cleft lip with cleft palate (UCLP) (Table 4). 
Fetuses got from group B had more of their secondary 
palate affected; this was noticed to be dose dependent 
(Table 4). The extent of malformation in both the primary 
and secondary palate from fetuses in group C was mild 
i.e. less than 50% (Table 4) while most of the fetuses 
showed no malformation.  




Table 3. Weights of the rat placenta (g) (mean ± SEM).  
 
Group Control Subgroup 1 (35 mg/kg) Subgroup 2 (70 mg/kg) 
A 2.22  ± 0.14 1.88  ± 0.12* 1.84  ± 0.10* 
B 2.26  ± 0.15 2.10  ± 0.16* 2.00  ± 0.22* 
C 2.28  ± 0.10 2.26  ± 0.38 2.04  ± 0.16* 
 




Table 4. Combination of various abnormalities of the palate and other abnormalities in rat fetuses. 
 
Viable fetuses BCLP UCLP NC CSP BCP UCL MA  
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BCLP = Bilateral cleft lip with cleft palate; UCLP = unilateral cleft lip with cleft palate; NC = no cleft at all; CSP = cleft of the secondary palate; BCL = bilateral cleft lip only; UCL = unilateral 






This study investigated the teratogenic  effect  of  
isotretinoin currently used in dermatological 
treatment on the fetuses of animals subjected to 
35 and 70 mg of isotretinoin per kg average body 
weight on days 11, 12 and 13 of gestation. This 
was in an attempt to verify the effect of the 
systemic use of isotretinoin on the merging of the 
maxillary prominences with the medial nasal 
prominences, the elevation of the palatal shelves 
and the possibili-ties of other morphological 
resorptions. Although the mechanism of action of 
isotretinoin leading to the drop in fur of the treated 
group is still unclear but it is known that like other 
retinoids, isotretinoin works by altering DNA 
transcription (Bremner, 2003). 
This effect decreases the size and output of se-
baceous glands, makes the cells that are 
sloughed off into the sebaceous glands less stic-
ky, and therefore less able to form comedones. A 
loss in the weight of the maternal after delivery as 
compared to the weight before gestation and the 
control group (Table 1) could be a symptom of ill 
health which must have been caused by the 
release of free radicals. This is related to the 
investigation of Akpantah et al. (2006) who also 
discovered the same symptom in Sprague-Dawley 
rat administered with alcohol. Halliwell and 
Gutteridge (1999) also related systemic toxicity to 
the release of free radicals and hence a loss in 
weight which is an index of ill health. Although 
Kocchar and Penner (1987) said this drug has a 
low toxicity in pregnant mice, they also concluded 
that continuous use of this drug might cause 
defect in organs. The same toxicity was reflected 
in the significant weight loss in the fetuses of the 
treated group as compared with the control (Table 
2). This weight loss is concomitant with the 
reduction in the crown-rump length of the fetuses 
(Table 2). This suggests that even though all the 





isotretinoin at certain critical period is teratogenic 
(Webster et al.,1986). The work of Kocchar (1967) which 
affirms the ability of isotretinoin to cross the placenta, 
explains the reason for the weight loss (Table 3).  
The mechanism of action of isotretinoin on the placenta 
has not been completely elucidated, but may be 
connected with the reduction in the fibers of the 
connective tissues in the villus core of the placenta 
membrane (Sadler, 1995). These fibers which are 
expected to provide the placenta with the pulsatile flow of 
the exchanged metabolites and gaseous products 
between maternal and fetal blood stream must have been 
impeded by the systemic presence of isotretinoin. The 
weight loss in the placenta of the treated group is dose 
dependent (P >0.05) which affirms its severity when 
taken in high quantity. Shalita et al. (1983) on their work 
on the teratogenic effect of isotretinoin in humans, 
revealed that it cause multiple lesions as congenital 
malformation. It was, however, not surprising when 
congenital malformation of the palate with cleft lip was 
the aftermaths of this investigation. The effect of 
isotretinoin on primary palate which is lacking in 
information was studied together with the philtrum and 
the secondary palate. 
 Data from the results (Table 4) showed that group A 
which was administered with isotretinoin on day 11 of 
gestation, had more of their primary palate malformed. 
Bilateral cleft lip with cleft palate was predominant (78.61 
and 88.89% for subgroups 1 and 2, respectively). This 
could be due to the teratogenic influence of isotretinoin 
on the crest cells migrating into the region of fusion of the 
maxillary prominences with the medial nasal promi-
nences on both sides (Sadler, 1995) consequently 
preventing the mesenchymal masses in the maxillary 
prominences to meet and unit with the merged medial 
nasal prominences. Fetuses got from group B had most 
of their secondary palate affected (50.00 and 71.43% for 
subgroups 1 and 2, respectively) (Table 4). This may be 
related to the administration of isotretinoin at the critical 
period when the palatal shelves are to elevate.  
The works of Webster et al. (1986) and Ritchie and 
Webster (1991) revealed that this drug in vitro or in vivo 
administered 6 h before cell migration from the neural 
crest was sufficient to induce severe defects in the 
second branchial arch in the great majority of the 
exposed embryos. Fetuses from group C had only mild 
malformation both in the primary and secondary palate 
(28.57 and 35.72% for sub groups 1 and 2 respectively). 
The reasons for this is still being investigated, but it is 
believed to be due to successful migration of some crest 
cells before the presence of the teratogen (isotretinoin) 
which eventually arrested further migration of the crest 
cells and hence, inhibit development of the structures 
involved.  
The result also revealed that there are no external 
assaults on the fetuses by isotretinoin; but that does not 
mean other organs in the body are  not  vulnerable  if  the  




teratogen (isotretinoin) is present during organogenesis. 
This therefore calls for more investigation. In conclusion, 
cystic acne, skin cancers and other related infections 
common with pregnant women should be courteously 
treated if isotretinoin is to be employed at all; most  






The authors are sincerely grateful to the staff of the 
Biochemistry Department, University of Ilorin, Ilorin, 






Akpantah AO, Olabiyi OA, Oremosu AA, Noronha CC Okanlawon AO 
(2006). Assessment of the antioxidant potential of alcoholic extract of 
Garcinia kola seed in alcohol induced testicular oxidative stress in 
Spague-Dawley rat. Nig. J. Health BioMed Sci. 5(1): 37-42. 
Amichai B, Shemer A, Grunwald M (2006). "Low-dose isotretinoin in the 
treatment of acne vulgaris". J. Am. Acad. Dermatol. 54 (4): 644–6. 
Bremner JD (2003). Does isotretinoin cause depression and suicide? 
Psychopharmacol Bull; 37(1):64-78. 
Chee Hong N, Isaac S (2003) The association between depression and 
isotretinoin use in acne, Austr. N. Z. J. Psychiatry 37(1): 78-84. 
Di-Giovanna JJ (1992). Retinoids for the future: oncology. J Acad 
Dermatol 27: 534-537. 
Eleny BR, Karina GS, Maria AJ (2001). effect of isotretinoin on tooth 
germ and palate development in mouse embryos. Braz. Dent. J. 
12(2): 115-119 ISSN 0103-6440 
Eun-Hwang J, Jae-Sook R, Chi-Seok A (1996). Elevated maternal 
serum Alpha-Fetoprotein in cleft lip and palate. Chungbuk Med. J. 
6(1): 149-153. 
Gregg NM (1941). Congenital cataract following German measles in 
mothers. Trans ophthamol Soc Aust. 3: 35. 
Halliwell B, Gutteridge M (1999). Reproduction and oxidative stress. 
Free radicals in Biology and Medicine 2nd ed. Oxford Uni. Press. New 
york; 522-529. 
Hendrickx AG, Silverman S, Pellegrini M, Steffek AJ (1980). 
Teratological and radiocephalometric analysis of craniofacial 
malformation induced with retinoic acid in “Rhesus monkeys”. 
Teratology; 22: 13-22.S 
Hong Ng C, Schweitzer I (2003). The association between depression 
and isotretinoin use in acne Australian and New Zealand Journal of 
Psychiatry 37 (1): 78–84. 
Kirschner RE, LaRossa D (2000). Syndromic and other congenital 
anomalies of the head and neck. Otolaryngologic Clinics of North 
America. 33 (6): 1191-1215.  
Kocchar DM (1967). Teratogenic activity of retinoic acid. Acta. Pathol. 
Microb. Scand; 70:398-404. 
Kocchar PM, Penner JD (1987). Development effect of Isotretinoin and 
4-oxo-isotretinoin: The role of metabolism in teratogenicity. 
Teratology; 36: 65-75. 
Kronmiller JE, Upholt WB, Koller GJ (1992). Retinol alters murine 
odontogenesis patterning and prolongs EGFm RNA expression in 
vitro. Arch. Oral. Biol. 37:129-138. 
Lammer EJ, Chen DT, Hoar RM, Agnish ND, Benke PJ, Braun JT 
(1985). Retinoic acid embryopathy. N. Engl. J. Med., 313: 837-41. 
Lorente CA, Miller SA (1978). Vitamin A induction of cleft palate. Cleft 
palate J; 15: 378-385. 
Mandi AM (1951). Cyclic changes in the vaginal smear of adult 
variectomized rat. J. Exp. Biol. 28: 585-592. 
O'Donnell J (2003). Overview of existing research and information 
linking isotretinoin (accutane), depression, psychosis, and suicide. 
Am. J. Ther. 10(2):148-59. 




Ofusori DA (2003). Effect of different concentrations of isotretinoin on 
palate development in rat fetuses. B Sc. Thesis, University of Ilorin, 
Ilorin, Nigeria. 
Ritchie H, Webster WS (1991). Parameters determining isotretinoin 
teratogenicity in rats’ embryo culture. Teratology 43:71-81. 
Sadler TWE (1995). Langman’s medical embryology 7th ed. pp. 333-
340. 
Shalita AR, Cunningham WJ, Leyden JJ, Pochi PE, Staruss JS (1983) 
Isotretinoin treatment of acne and related disorders: An update. J Am 



















Webster WS, Johnston ST, Lammer GJ, Sulikk KK (1986) Isotretinoin 
embriopathy and cranial neural crest. An in vivo study. J. Craniofac. 
Genet Dev Bio; 6: 211-222. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
